Aripiprazole for the treatment and prevention of acute manic and mixed episodes in bipolar disorder in children and adolescents
| Status: |
In progress |
| Expected date of issue: |
February 2013 |
| Referral date: |
January 2010 |
| Wave: |
22 |
| Process: |
STA |
Topic area:
-
Mental health and behavioural conditions
|
NICE project team
| Executive Lead: |
TBC
|
| Technical Lead: |
Bernice Dillon
|
| Communications manager: |
Alice Law
|
| Project manager: |
Bijal Joshi
|
Provisional schedule
| Closing date for invited submissions / evidence submission: |
15 June 2012 |
| 1st appraisal committee meeting: |
18 September 2012 |
| 2nd appraisal committee meeting |
20 November 2012 |
Consultees and commentators
Project history
| Date |
Update |
| 27 January 2012 |
Following on from advice received from the manufacturer, this appraisal has been rescheduled to align with latest regulatory expectations. Therefore, we now anticipate that the appraisal will begin during mid April 2012 when we will write to you about how you can get involved. The deadline for submissions is expected in approximately mid June 2012. |
| 12 August 2011 |
As you are aware, the Department of Health has asked us to carry out a single technology appraisal of aripiprazole for the treatment and prevention of acute manic and mixed episodes in bipolar disorder in children and adolescents.
Please note that following on from advice received from the manufacturer, we now anticipate that the appraisal will begin during early March 2012 when we will write to you about how you can get involved. The deadline for submissions is expected in approximately early May 2012. |
|
Key documents
This page was last updated: 25 April 2012
